bf/NYSE:BMY_icon.jpeg

NYSE:BMY

Bristol Myers Squibb

  • Stock

USD

Last Close

45.27

26/07 20:00

Market Cap

83.35B

Beta: 0.43

Volume Today

31.41M

Avg: 7.82M

PE Ratio

11.94

PFCF: 8.37

Dividend Yield

4.80%

Payout:57.08%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.58B
-
1.53B
3.07%
1.39B
9.06%
1.23B
11.47%
1.20B
2.23%
1.18B
1.91%
2.74B
132.44%
3.18B
16.02%
2.08B
34.52%
2.22B
6.36%
2.50B
12.79%
average payables
2.38B
-
2.52B
5.99%
2.03B
19.70%
1.61B
20.31%
1.96B
21.15%
2.07B
5.83%
2.17B
4.76%
2.58B
18.93%
2.83B
9.77%
2.99B
5.78%
3.15B
5.18%
average receivables
3.22B
-
3.38B
4.76%
3.84B
13.91%
4.92B
28.00%
5.92B
20.33%
6.13B
3.56%
6.83B
11.29%
8.09B
18.58%
10.51B
29.85%
13.23B
25.86%
12.43B
6.03%
book value per share
9.22
-
8.96
2.76%
8.56
4.52%
9.68
13.12%
7.14
26.27%
8.59
20.38%
30.26
252.21%
16.75
44.65%
16.70
0.33%
14.43
13.59%
capex per share
-0.33
-
-0.32
2.82%
-0.49
54.96%
-0.73
47.82%
-0.64
11.80%
-0.58
9.20%
-0.49
15.80%
-0.33
31.99%
-0.45
35.52%
-0.52
14.90%
capex to depreciation
-0.70
-
-1.13
60.04%
-2.18
93.62%
-3.18
45.84%
-1.34
57.96%
-1.49
11.65%
-0.48
67.93%
-0.07
84.85%
-0.09
25.52%
-0.11
19.49%
-0.12
13.86%
capex to operating cash flow
-0.15
-
-0.17
10.30%
-0.45
167.88%
-0.43
4.75%
-0.20
53.09%
-0.16
19.95%
-0.10
35.27%
-0.05
48.29%
-0.06
12.03%
-0.09
42.52%
-0.09
1.94%
capex to revenue
-0.03
-
-0.03
1.07%
-0.05
49.48%
-0.06
26.30%
-0.05
18.81%
-0.04
16.99%
-0.03
24.14%
-0.02
44.61%
-0.02
18.44%
-0.02
15.46%
-0.03
10.91%
cash per share
2.75
-
4.49
63.02%
2.56
42.91%
3.80
48.36%
4.14
8.97%
5.44
31.38%
9.03
65.95%
7.01
22.34%
8.00
14.09%
4.30
46.27%
days of inventory on hand
118.37
-
144.81
22.33%
114.01
21.27%
91.58
19.67%
70.16
23.39%
66.62
5.04%
193.98
191.16%
64.30
66.85%
76.93
19.64%
84.22
9.48%
90.87
7.89%
days payables outstanding
202.22
-
230.86
14.17%
146.13
36.70%
122.80
15.97%
135.27
10.15%
105.48
22.02%
110.48
4.74%
84.11
23.86%
108.29
28.74%
109.46
1.08%
111.24
1.63%
days sales outstanding
74.85
-
77.92
4.11%
94.75
21.60%
104.14
9.91%
110.68
6.28%
96.50
12.81%
107.29
11.17%
72.98
31.98%
98.49
34.96%
110.21
11.90%
88.57
19.63%
debt to assets
0.22
-
0.23
7.38%
0.21
9.21%
0.20
5.54%
0.24
19.25%
0.69
190.53%
0.37
46.94%
0.44
19.21%
0.42
4.36%
0.42
0.82%
0.42
0.62%
debt to equity
0.55
-
0.53
4.18%
0.47
11.09%
0.41
11.56%
0.68
63.54%
0.52
22.76%
0.92
75.90%
1.37
48.29%
1.27
7.16%
1.31
3.34%
1.35
3.09%
dividend yield
0.03
-
0.02
7.22%
0.02
11.89%
0.03
20.75%
0.03
1.99%
0.03
20.42%
0.02
20.48%
0.03
18.86%
0.03
12.56%
0.03
8.65%
earnings yield
0.03
-
0.02
30.15%
0.01
30.88%
0.05
222.28%
0.01
78.11%
0.06
484.00%
0.03
46.14%
-0.06
304.38%
0.05
181.13%
0.04
21.61%
enterprise value
92.13B
-
100.07B
8.62%
118.98B
18.89%
100.12B
15.85%
103.35B
3.22%
85.32B
17.44%
144.64B
69.52%
177.19B
22.51%
165.86B
6.40%
186.50B
12.45%
28.31B
84.82%
enterprise value over ebitda
28.52
-
46.89
64.40%
48.88
4.24%
17.83
63.53%
18.07
1.40%
14.05
22.24%
21.92
55.96%
11.96
45.44%
8.22
31.28%
9.36
13.91%
1.64
82.46%
ev to operating cash flow
25.99
-
31.79
22.32%
64.94
104.29%
35.13
45.91%
19.59
44.23%
14.36
26.68%
17.93
24.82%
12.61
29.67%
10.23
18.84%
14.27
39.48%
2.04
85.69%
ev to sales
5.62
-
6.30
12.08%
7.18
14.00%
5.15
28.27%
4.97
3.48%
3.78
23.97%
5.53
46.28%
4.17
24.67%
3.58
14.20%
4.04
13.00%
0.63
84.43%
free cash flow per share
1.83
-
1.58
13.52%
0.61
61.64%
0.98
61.17%
2.57
162.18%
3.06
19.09%
4.24
38.82%
5.89
38.87%
7.08
20.14%
5.55
21.57%
free cash flow yield
0.03
-
0.03
22.13%
0.01
67.08%
0.02
89.72%
0.04
150.03%
0.06
40.40%
0.07
12.41%
0.09
43.71%
0.11
19.52%
0.08
32.03%
graham net net
-9.47
-
-4.83
48.94%
-5.53
14.43%
-3.73
32.56%
-5.83
56.21%
4.05
169.44%
-32.22
896.56%
-25.40
21.18%
-21.20
16.52%
-20.82
1.81%
graham number
17.98
-
15.62
13.15%
13.70
12.30%
24.10
75.99%
9.91
58.87%
24.21
144.20%
37.06
53.06%
38.75
4.55%
34.93
9.84%
30.89
11.59%
income quality
1.37
-
1.55
12.92%
1.12
27.60%
0.63
43.70%
5.41
755.58%
1.20
77.81%
2.33
94.17%
-1.56
167.00%
2.31
247.91%
2.06
10.88%
1.72
16.29%
intangibles to total assets
0.24
-
0.26
6.65%
0.26
0.49%
0.25
6.27%
0.24
1.81%
0.72
197.46%
0.67
7.04%
0.62
6.39%
0.58
7.06%
0.59
2.60%
0.51
14.64%
interest coverage
14.73
-
8.44
42.67%
9.40
11.36%
27.18
189.08%
17.60
35.24%
27.97
58.89%
8.33
70.22%
3.61
56.64%
7.62
110.88%
8.38
10.08%
interest debt per share
5.19
-
4.85
6.64%
4.12
14.97%
4.11
0.21%
4.96
20.54%
4.61
6.99%
28.27
512.84%
23.51
16.82%
21.80
7.30%
19.48
10.61%
inventory turnover
3.08
-
2.52
18.26%
3.20
27.02%
3.99
24.49%
5.20
30.53%
5.48
5.31%
1.88
65.65%
5.68
201.67%
4.74
16.42%
4.33
8.66%
4.02
7.31%
invested capital
0.55
-
0.53
4.18%
0.47
11.09%
0.41
11.56%
0.68
63.54%
0.52
22.76%
0.92
75.90%
1.37
48.29%
1.27
7.16%
1.31
3.34%
1.35
3.09%
market cap
87.38B
-
97.81B
11.94%
114.67B
17.24%
97.65B
14.84%
100.81B
3.23%
84.88B
15.80%
109.44B
28.93%
140.06B
27.98%
134.24B
4.16%
154.91B
15.40%
net current asset value
-4.44B
-
-4.16B
6.35%
-6.91B
66.16%
-3.66B
47.08%
-6.85B
87.36%
1.53B
122.41%
-48.89B
3,285.15%
-50.41B
3.10%
-40.05B
20.55%
-38.43B
4.04%
-33.90B
11.77%
net debt to ebitda
1.47
-
1.06
28.01%
1.77
66.90%
0.44
75.12%
0.44
1.02%
0.07
83.76%
5.33
7,291.83%
2.51
53.01%
1.57
37.48%
1.59
1.23%
1.64
3.53%
net income per share
1.56
-
1.21
22.42%
0.97
19.45%
2.67
173.79%
0.61
77.05%
3.03
395.37%
2.02
33.49%
-3.98
297.50%
3.25
181.55%
2.94
9.54%
operating cash flow per share
2.16
-
1.90
11.90%
1.10
42.15%
1.71
55.20%
3.21
88.01%
3.64
13.43%
4.73
30.07%
6.22
31.53%
7.53
20.96%
6.07
19.38%
payables turnover
1.81
-
1.58
12.41%
2.50
57.98%
2.97
19.00%
2.70
9.22%
3.46
28.24%
3.30
4.52%
4.34
31.34%
3.37
22.33%
3.33
1.07%
3.28
1.60%
receivables turnover
4.88
-
4.68
3.95%
3.85
17.76%
3.50
9.02%
3.30
5.91%
3.78
14.69%
3.40
10.05%
5.00
47.01%
3.71
25.90%
3.31
10.63%
4.12
24.43%
research and ddevelopement to revenue
0.23
-
0.29
25.39%
0.36
25.20%
0.25
28.87%
0.31
21.35%
0.28
8.86%
0.24
16.39%
0.26
11.45%
0.22
16.14%
0.21
6.27%
0.21
0.30%
return on tangible assets
0.09
-
0.08
8.63%
0.07
13.71%
0.18
152.89%
0.04
77.43%
1.63
4,034.98%
0.08
95.16%
-0.20
354.51%
0.15
175.48%
0.16
5.93%
0.17
6.29%
revenue per share
9.97
-
9.58
3.85%
9.93
3.66%
11.63
17.03%
12.63
8.63%
13.82
9.39%
15.33
10.99%
18.83
22.80%
21.54
14.42%
21.44
0.49%
roe
0.17
-
0.13
20.22%
0.11
15.63%
0.28
142.03%
0.09
68.87%
0.35
311.50%
0.07
81.12%
-0.24
456.83%
0.19
181.81%
0.20
4.69%
0.27
33.87%
roic
0.11
-
0.06
42.17%
0.06
0.01%
0.15
134.72%
0.03
77.98%
0.20
496.03%
0.04
80.83%
0.07
95.11%
0.11
43.62%
0.12
8.97%
0.24
104.42%
sales general and administrative to revenue
0.01
-
0.06
448.45%
0.01
82.51%
0.00
51.52%
0.01
66.46%
shareholders equity per share
9.22
-
8.96
2.76%
8.56
4.52%
9.68
13.12%
7.14
26.27%
8.59
20.38%
30.26
252.21%
16.75
44.65%
16.70
0.33%
14.43
13.59%
stock based compensation to revenue
0.01
-
0.01
15.07%
0.01
5.79%
0.01
25.64%
0.01
9.23%
0.01
2.27%
0.02
72.19%
0.02
8.62%
0.01
31.40%
0.01
21.23%
0.01
16.25%
tangible asset value
5.82B
-
6.20B
6.54%
6.12B
1.27%
8.09B
32.05%
3.77B
53.33%
-4.32B
214.44%
-34.76B
704.79%
-35.91B
3.31%
-27.27B
24.05%
-26.39B
3.25%
-18.76B
28.92%
tangible book value per share
3.54
-
3.74
5.71%
3.67
1.87%
4.84
31.74%
2.29
52.59%
-2.64
215.28%
-20.39
670.81%
-15.90
21.99%
-12.67
20.35%
-12.26
3.25%
working capital
6.48B
-
6.15B
5.08%
2.40B
60.99%
4.86B
102.79%
5.29B
8.80%
7.18B
35.72%
11.05B
53.88%
11.11B
0.56%
11.39B
2.54%
5.38B
52.76%
9.51B
76.63%

All numbers in USD (except ratios and percentages)